mni-1054
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 9, 2018 (NCT03695926)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
KDM1A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04202497 | Phase 1 | Dec 16, 2019 | Takeda |
| NCT03719482 | Phase 1 | Oct 5, 2018 | Invicro |
| NCT03695926 | Early Phase 1 (Phase 1) | Aug 9, 2018 | Invicro |
Showing 3 of 3 trials
Page 1 / 1